(Q54026624)

23 May 2018

title

Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study. (English)

1 reference

23 May 2018

author name string

Brenner B

1

1 reference

23 May 2018

Wainberg MA

2

1 reference

23 May 2018

Salomon H

3

1 reference

23 May 2018

Rouleau D

4

1 reference

23 May 2018

Dascal A

5

1 reference

23 May 2018

Spira B

6

1 reference

23 May 2018

Sekaly RP

7

1 reference

23 May 2018

Conway B

8

1 reference

23 May 2018

Routy JP

9

1 reference

23 May 2018

publication date

1 December 2000

1 reference

23 May 2018

International Journal of Antimicrobial Agents

published in

1 reference

23 May 2018

volume

16

1 reference

23 May 2018

issue

4

1 reference

23 May 2018

page(s)

429-434

1 reference

23 May 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Virological and clinical implications of resistance to HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Transmission of zidovudine-resistant HIV-1 through heterosexual contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Transmission of multidrug-resistant human immunodeficiency virus--the wake-up call

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Comparison of cord blood and peripheral blood mononuclear cells as targets for viral isolation and drug sensitivity studies involving human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900270-3

7 January 2021

10.1016/S0924-8579(00)00270-3

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018